SCM
BIOA

Sterling Capital Management’s BioAge Labs BIOA Stock Holding History

Sterling Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5K Sell
1,000
-367
-27% -$7.07K ﹤0.01% 2079
2025
Q4 		$18.1K Sell
1,367
-270
-16% -$2.39K ﹤0.01% 2282
2025
Q3 		$9.63K Buy
1,637
+997
+156% +$4.67K ﹤0.01% 2505
2025
Q2 		$2.64K Buy
640
+532
+493% +$2.14K ﹤0.01% 2836
2025
Q1 		$406 Sell
108
-76
-41% -$351 ﹤0.01% 2998
2024
Q4 		$1.06K Buy
+184
New +$3.17K ﹤0.01% 2930

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Sterling Capital Management's BIOA Position: Q1 2026 in Review

Sterling Capital Management reduced its BioAge Labs (BIOA) stake by 27% in Q1 2026, selling an estimated $7.07K and leaving 1,000 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Sterling Capital Management first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. The position peaked at $18.1K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Sterling Capital Management held 1,000 shares of BioAge Labs worth $17.5K as of Q1 2026.
  • Sterling Capital Management sold 367 BioAge Labs shares in Q1 2026, an estimated $7.07K.
  • BioAge Labs made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2079 holding.
  • Sterling Capital Management first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • Sterling Capital Management's BioAge Labs position peaked at $18.1K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.